SOPH SOPHiA GENETICS S.A.: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

SOPHiA GENETICS SA - graphic logo of issuer SOPH

SOPHiA GENETICS SA (SOPH) develops cloud IT solutions for precision medicine, leveraging external server capacities and remote support to drive global growth. This chart of historical price action reflects that the EV/EBITDA currently stands at 0.00. SOPHiA GENETICS SA (SOPH) maintains its market position due to the complexity of clinics switching to alternative software and its AI-driven therapy selection. The network effect expands the competitive moat: the more data the platform processes, the more valuable it becomes for physicians.

SOPHiA GENETICS - SOPH Business Value to Operating Income Before Depreciation (period 11/23/2025 - 11/11/2026)

Metric breakdowns and analytics for sophiagenetics.com (SOPH)

- market price and analyst price targets:
Price Chart SOPHiA GENETICS|SOPH - Average Forecast Price
- company stock capitalization data:
Market Value SOPH|SOPH - Full Business Value
- book value of equity indicators:
Book Value per Share SOPHiA GENETICS SA|SOPH - Accounting Value of Company|Market Capitalization to Book Value Ratio sophiagenetics.com|SOPH - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Capital SOPHiA GENETICS SA|SOPH - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio SOPHiA GENETICS|SOPH - Aggregate Debt Obligations|Debts to Book Capitalization SOPH|SOPH - Long-Term Indebtedness|Company Short-Term Debts SOPHiA GENETICS SA|Quick Liquidity sophiagenetics.com
- financial results and valuation multiples details:
SOPH - Company Profit|Projected Future Earnings SOPHiA GENETICS SA|SOPH - Market Cap to Earnings|Projected Price to Earnings SOPHiA GENETICS|SOPH - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple SOPH|SOPH - Operating income before deduction of amortization|Net earnings per share (EPS TTM) SOPHiA GENETICS SA|SOPH - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months sophiagenetics.com|SOPH - Expected net earnings per share growth this year|Expected earnings per share growth for next year SOPHiA GENETICS SA
Summary company analysis:SOPHiA GENETICS S.A. SOPH
Product sample of Sophia Genetics

SOPHiA GENETICS SA is developing cloud-based AI data analysis for clinical genomics, leveraging an extensive database of patient profiles. The EV/EBITDA multiple dynamics for this capital-intensive enterprise reflect the total enterprise value, including debt, relative to operating income before depreciation and amortization. This ratio allows for an assessment of the company's actual capital revaluation during periods of market consolidation. A decline in this metric to historical lows signals that the asset is undervalued, yet warns of potential business stagnation risks.

Main competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|Doximity Network (DOCS) - Company Value to EBITDA|HQY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio WAY|CRVL: EV/EBITDA Multiple|Privia Health Group, Inc. - Business Value to Operating Income Before Depreciation|HURN (Huron Consulting) - EV/EBITDA Multiple|Certara Software (CERT) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple OMCL|EV/EBITDA Multiple goodrx.com (GDRX)|Schrödinger - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation PHR|Omada Health Corp - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Evolent Corp (EVH)|HSTM: EV/EBITDA Multiple|Company Value to EBITDA definitivehc.com (DH)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Consensus Cloud Solutions, Inc.|Enterprise Value to Operating Income Before Depreciation AGL (agilon health, inc.)|EV/EBITDA Multiple ABSI|SY - Company Value to EBITDA|National Research - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio SPOK (spok.com)|OptimizeRx - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio TruBridge Inc TBRG|SLP: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Health Catalyst Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareCloud Inc.|researchsolutions.com (RSSS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scienture Holdings Inc. SCNX|Total Company Value to Operating Income Before Depreciation Ratio Healthcare Triangle Corporation (HCTI)|iSpecimen Corp - EV/EBITDA Multiple|BFRG - EV/EBITDA Multiple|SCWorx (WORX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MSPR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iCoreConnect, Inc.|Company Value to EBITDA TRxADE Health Corp MEDS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orgenesis Inc. (ORGS)|RCM: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SHCR (Sharecare)|Business Value to Operating Income Before Depreciation STRM|Syra Health Corporation - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Apollo Medical Holdings AMEH|MODN (Model N, Inc.) - Enterprise Value to EBITDA Ratio|NXGN: Enterprise Value to Operating Income Before Depreciation Ratio